Efficacy and Safety of <i>Houttuynia</i> Eye Drops Atomization Treatment for Meibomian Gland Dysfunction-Related Dry Eye Disease: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial

scientific article published on 12 December 2020

Efficacy and Safety of <i>Houttuynia</i> Eye Drops Atomization Treatment for Meibomian Gland Dysfunction-Related Dry Eye Disease: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3390/JCM9124022
P698PubMed publication ID33322753

P50authorZhaolin LiuQ104478242
P2093author name stringLei Li
Ying Li
Jun Liu
Zhiqiang Pan
Zuguo Liu
Ming Jin
Hongsheng Bi
Minglian Zhang
Xiaofeng Xie
Huijun Shi
Yiran Yang
Liying Tang
Xuemin Gao
Weijie Ouyang
Xianghua Xiao
Jieli Wu
Jiaoyue Hu
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue12
P921main subjecteye diseaseQ3041498
P577publication date2020-12-12
P1433published inJournal of Clinical MedicineQ27724774
P1476titleEfficacy and Safety of <i>Houttuynia</i> Eye Drops Atomization Treatment for Meibomian Gland Dysfunction-Related Dry Eye Disease: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial
P478volume9

Search more.